ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

0.49
-0.0165
(-3.26%)
Closed March 06 3:00PM
0.49
0.00
(0.00%)
After Hours: 6:49PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 11.03M47.6M5.13M7.32M231k5.68M128.23M40.9M
Operating Income -27.18M1.55M-22.94M-46.3M-28.32M-49.02M68.57M-11.25M
Pre Tax Income -28.26M1.66M-20.71M-44.91M-48.57M-47.98M70.05M-16.79M
Net Income -29.25M1.04M-21.39M-45.6M-47.92M-48.5M69.52M-17.62M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -28.72M1.55M-23.11M-46.63M-28.63M-49.02M68.57M-13.91M
EBITDA -25.74M3.39M-20.71M-43.41M-25.45M-46.19M71.31M-8.43M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 14.2M37.83M59.51M1.12M3.96M6.15M27.15M60.28M
Operating Income -75.77M-86.35M-98.61M-138.62M-133.58M-157.85M-166.4M-118.3M
Pre Tax Income -73.78M-80.45M-107.72M-136.92M-129.93M-157.3M-162.96M-112.54M
Net Income -68.8M-71.31M-91.56M-137.17M-130.09M-158.09M-165.46M-113.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.162-0.127-0.146-0.217-0.14-0.169-0.168-0.084
EBIT -75.89M-86.54M-98.62M-138.62M-133.58M-157.85M-166.4M-118.3M
EBITDA -72.48M-80.93M-90.8M-130.61M-125.98M-151.29M-160.33M-108.46M